Stage III Renal Cell Cancer AJCC v7
Showing 1 - 12 of 12
Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Akt Inhibitor MK2206
- Hydroxychloroquine
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 25, 2023
Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder
Active, not recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +35 more
- Cabozantinib S-malate
- +2 more
-
Duarte, California
- +7 more
Jan 3, 2023
Metastatic Renal Cell Carcinoma, Sarcomatoid Renal Cell Carcinoma, Stage II Renal Cell Cancer AJCC v7 Trial in Canada, Israel,
Active, not recruiting
- Metastatic Renal Cell Carcinoma
- +4 more
- Nephrectomy
- +4 more
-
Birmingham, Alabama
- +414 more
Dec 30, 2022
Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States
Active, not recruiting
- Clear Cell Renal Cell Carcinoma
- +3 more
- Aldesleukin
- +6 more
-
Los Angeles, California
- +3 more
Nov 16, 2022
Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in Houston (other,
Completed
- Clear Cell Renal Cell Carcinoma
- +3 more
- Laboratory Biomarker Analysis
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 30, 2022
Locally Advanced Papillary Renal Cell Carcinoma, Metastatic Papillary Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7
Active, not recruiting
- Locally Advanced Papillary Renal Cell Carcinoma
- +6 more
- Cabozantinib S-malate
- +3 more
-
Anchorage, Alaska
- +596 more
Aug 2, 2022
Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer AJCC v6 and v7, Stage II Renal Cell Cancer AJCC v7 Trial in Canada,
Completed
- Clear Cell Renal Cell Carcinoma
- +3 more
- Laboratory Biomarker Analysis
- +4 more
-
Birmingham, Alabama
- +986 more
Jan 13, 2022
Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7, Stage IV Renal Cell Cancer AJCC v7 Trial in Bronx, New York
Completed
- Recurrent Renal Cell Carcinoma
- +2 more
- Capecitabine
- +2 more
-
Bronx, New York
- +3 more
Mar 17, 2021
Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States
Completed
- Clear Cell Renal Cell Carcinoma
- +3 more
- Cabozantinib S-malate
- +2 more
-
Mobile, Alabama
- +487 more
Jan 28, 2021
Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Stage I Renal Cell Cancer AJCC v6 and v7 Trial in New York
Terminated
- Clear Cell Renal Cell Carcinoma
- +5 more
- Metastasectomy
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 22, 2020
Metastatic Kidney Carcinoma, Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States (Akt
Terminated
- Metastatic Kidney Carcinoma
- +3 more
- Akt Inhibitor MK2206
- +2 more
-
Beverly Hills, California
- +7 more
Sep 25, 2019
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States
Terminated
- Clear Cell Renal Cell Carcinoma
- +3 more
- Bevacizumab
- +3 more
-
Scottsdale, Arizona
- +523 more
Mar 5, 2019